@LabRobbiani

Account run by lab members.

 Bellinzona, Switzerland
irb.usi.ch/immunology-and-infectious-disease/
Joined October 2021
  • Tweets10
  • Following38
  • Followers56
2Media
Yay🥳Another paper from our lab was recently published in @NatImmunol. Jonathan and Valentina discovered chemokines autoantibodies associated with a favorable course of COVID-19 disease! Huge thanks to everyone involved! @BellinzonaIrb @HUNIMED @universitybern @UZH_en
2
1
1
13
2,459
On 24th of July, Filippo successfully defended his PhD thesis and became the first PhD awarded in our lab! Big congratulations, Dr. Bianchini! 🥳 @LabRobbiani @BellinzonaIrb @USI_en
2
68
Human spring rolls wish you a happy summer! 😎🇨🇳
2
159
doi.org/10.1038/s41590-023-0…

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course

Nature Immunology - Robbiani and colleagues show that antibodies against specific chemokines are detected in COVID-19 convalescents and may modulate the inflammatory response and disease outcome.

nature.com
2
148
J. Muri, V. Cecchinato, M. Uguccioni and D. Robbiani won the @BiotestAG Award 2022 for their outstanding study titled «Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course». #SARSCoV2 #IRB #Biosplus Link: shorturl.at/jmwx8 @USI_en
1
1
8
917
Scientists discover antibodies that recognise all coronaviruses that cause human disease: the finding opens the door to the development of novel countermeasures against present and future #Coronavirus threats. #IRB Link: shorturl.at/fLNZ6 @CzechAcademy @Stanford @USI_en
2
16
752
A new study identified “coldspot” regions conserved across different #SARSCoV2 variants and isolated antibodies able to bind to these regions and protect mice against infection. @BarnesLab1 @Stanford @USI_en 📄: scim.ag/1iW
21
4
55
13,680
We are happy to announce that the first paper of our lab was just released in @SciImmunology🥳 Congratulations to Filippo and Virginia and the other co-authors!👏 @CavalliLab @LabRuzek @BarnesLab1 @BellinzonaIrb science.org/doi/10.1126/scii…

Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike...

Virus coldspot-driven discovery reveals broadly cross-reactive antibodies that protect from SARS-CoV-2 variants.

science.org
3
5
29
5,357
The germinal centre B cell response to SARS-CoV-2 dlvr.it/SDrb8Z
4
104
19
292
Finally, Robbiani Lab has officially joined Twitter! Yaaay! 🥳🎉 @BellinzonaIrb @USI_en
2
Load more